Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.
Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).
Unsubstantiated QOL claim in the headline.
Revised to:
Consider ArradiCAN for your adult patients with metastatic NSCLC.
Verbatim indication to be moved below headline.